FDA Publishes Guidance Snapshots: Visual Communication Tool for Clinical Trial and Drug Development Guidance Documents

FDA Publishes Guidance Snapshots: Visual Communication Tool for Clinical Trial and Drug Development Guidance Documents

The U.S. Food and Drug Administration (FDA) has launched a pilot program for FDA guidance document snapshots. The visual guidance snapshots highlight key information from FDA guidance documents on topics that seek to modernize drug clinical trials and accelerate drug development.

FDA guidance documents represent the Agency’s current thinking on a particular topic. To support transparency and communication, the FDA has launched the Guidance Snapshot Pilot program for a subset of cross-cutting FDA guidance documents. Guidance snapshots provide background and highlights from FDA guidance documents using visual representations. The snapshots contain drug development timelines showing when to implement recommendations expressed in the guidance, as well as recap podcasts by the guidance authors. The pilot program is intended to increase stakeholder awareness and engagement for FDA guidance documents on innovative topics.

To learn more about the FDA Guidance Snapshot pilot program and to view the current guidance snapshots visit the FDA Guidance Snapshot Pilot website.